Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease

Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis

(2010) P. Erben et al.   HAEMATOLOGICA

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

(2009) F. H. Grand et al.   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy

(2009) Princess U. Ogbogu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies

(2009) Hideki Makishima et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammatory fibroid polyps harbour mutations in theplatelet-derived growth factor receptor alpha(PDGFRA)gene

(2008) H-U Schildhaus et al.   JOURNAL OF PATHOLOGY

Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions

(2008) J Score et al.   LEUKEMIA

Novel gain-of-function mutation in the extracellular domain of the PDGFRA gene in infant acute lymphoblastic leukemia with t(4;11)(q21;q23)

(2008) M Hiwatari et al.   LEUKEMIA